A61K 38/1754
Insulin-like growth factor binding proteins
Official title: {Insulin-like growth factor binding proteins}
A61K38/1754 (Insulin-like growth factor binding proteins) appears on 33 US grants and 70 published applications in this corpus.
Search patents in A61K- Granted patents
- 33
- Published applications
- 70
- Assignees
- 39
- Inventors
- 117
- Latest grant
- 14 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 1 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 3 |
| 2008 | 0 | 0 |
| 2009 | 1 | 2 |
| 2010 | 0 | 3 |
| 2011 | 2 | 2 |
| 2012 | 1 | 1 |
| 2013 | 3 | 4 |
| 2014 | 1 | 4 |
| 2015 | 1 | 3 |
| 2016 | 4 | 5 |
| 2017 | 0 | 3 |
| 2018 | 0 | 1 |
| 2019 | 5 | 8 |
| 2020 | 1 | 2 |
| 2021 | 3 | 4 |
| 2022 | 3 | 4 |
| 2023 | 1 | 6 |
| 2024 | 4 | 8 |
| 2025 | 1 | 2 |
| 2026 | 1 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for treating chronic lung diseases14 Jul 2026US 12,678,482 B2Oak Hill Bio Limited
- Modulation of mammalian cell lineage by synthetic immodulins9 Sep 2025US 12,410,220 B2
- Non-recombinant human insulin-like growth factor binding protein concentrate10 Dec 2024US 12,167,255 B2Siemens Healthcare Diagnostics Inc.
- Use of IGFBP7 for treating malaria8 Oct 2024US 12,109,253 B2Agency for Science, Technology and Research
- Immodulator peptides covalently modified with small molecules1 Oct 2024US 12,102,685 B2
- Combination therapy for preterm infants27 Aug 2026US 2026/0248894 A1
- Modulating Neuroinflammation6 Aug 2026US 2026/0224662 A1Massachusetts Eye and Ear Infirmary
- Method of treating neonates with igf-1 complex26 Mar 2026US 2026/0083823 A1Oak Hill Bio Limited
- Human umbilical cord composition for treatment of peyronie's disease12 Jun 2025US 2025/0186506 A1Biostem Technologies, Inc.
- Non-recombinant human insulin-like growth factor binding protein concentrate2 Jan 2025US 2025/0008349 A1Siemens Healthcare Diagnostics Inc.
Most cited
By later US patents
- Combination PDGF, KGF, IGF, and IGFBP for wound healing30US 6,903,078 B1Chiron Corporation · 2005
- Methods and compositions for wound healing22US 8,247,384 B2CoDa Therapeutics, Inc. · 2012
- Methods and compositions for diagnosis and prognosis of renal injury and renal failure16US 10,300,108 B2Astute Medical, Inc. · 2019
- Molecules and methods for treatment and detection of cancer6US 9,060,961 B2University of Washington · 2015
- Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite-stimulation4US 7,981,860 B22011